Assessing the ED Stroke Patient for Disability - What Are the Pitfalls and How to Avoid Them?

December 2, 2020
The NIH Stroke Scale is beneficial when used correctly but is has its limitations. Relying entirely on the NIHSS will miss significant disability in a number of patients. Acute stroke care demands more than just an NIHSS assessment.
0 Comments

What Lessons Have You Learned About Endovascular Therapy in COVID Patients and What Should We All Know?

December 2, 2020
Acute interventional management during the COVID pandemic requires a change of focus and practice. Challenges abound and danger exists at every decision point.
0 Comments

Controversies in Prehospital Medicine: Choosing the Destination Medical Center for Stroke Patients

December 2, 2020
Once a stroke is suspected in the field, it stands to reason that the destination matters for the patient. But how much does it matter and where should patients be taken? Data meets politics in this compelling podcast.
0 Comments

When Might You Use Heparin in the NeuroICU for a Stroke Patient?

December 2, 2020
Heparin in stroke remains controversial. Understanding the history and data and essential to mastering stroke care.
0 Comments

Are the NNT and NNH for tPA Useful or Misleading in Acute Stroke Care?

December 2, 2020
Stroke treatment data are hard to interpret and can be misleading. A lot of misinformation has made its way into the literature and has confounded acute stroke care. Understanding NNT and NNH can help clinicians understand risks and benefits in a meaningful way.
0 Comments
RSS
First12345679
Categories
More Entries

Jun 28

Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?

Haemin Go posted on 6/28/2022


Moderator: Jordan Bonomo, MD, FCCM, FNCS
Other Participants: Chris Droege, PharmD, BCCCP, FCCM, FASHP and Christopher T. Richards, MD, MS, FAEMS, FACEP

Join this podcast to learn from EMS trained EM physician Dr. Richards and Critical Care Pharmacists Dr. Chris Droege as they tackle the sticky topic of how to reverse agents in ICH patients and whether or not to transfer these patients if specific reversal agents aren't available at first point of contact.  Factor neutralization, reversal, transfer protocols are all fair game in this fast moving podcast roundtable that touches on protocols, logistics and trial outcomes.


1 Comments

1 comments on article "Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?"

Avatar image

Alain Leif Santiago,DLA

as stated

Please login or register to post comments.